Search results for "drug research"

showing 10 items of 30 documents

Molecular topology as novel strategy for discovery of drugs with aβ lowering and anti-aggregation dual activities for Alzheimer's disease.

2014

Background and Purpose: In this study, we demonstrate the use of Molecular topology (MT) in an Alzheimer's disease (AD) drug discovery program. MT uses and expands upon the principles governing the molecular connectivity theory of numerically characterizing molecular structures, in the present case, active anti-AD drugs/agents, using topological descriptors to build models. Topological characterization has been shown to embody sufficient molecular information to provide strong correlation to therapeutic efficacy. Experimental Approach: We used MT to include multiple bioactive properties that allows for the identification of multifunctional single agent compounds, in this case, the dual func…

Models MolecularDrug Evaluation Preclinicallcsh:MedicineDiseaseProtein aggregationBioinformaticsBiochemistryMechanical Treatment of SpecimensAnimal CellsMolecular Cell BiologyDrug DiscoveryMedicine and Health Scienceslcsh:ScienceTopology (chemistry)NeuronsMultidisciplinaryDrug discoveryMedicine (all)Anti aggregationNeurodegenerative DiseasesAnimal ModelsElectroporationTreatment OutcomeNeurologySpecimen DisruptionDatabases as TopicFemaleMolecular topologyAlzheimer's diseaseCellular TypesResearch ArticleDrug Research and DevelopmentMouse ModelsMice TransgenicComputational biologyBiologyResearch and Analysis MethodsProtein AggregatesModel OrganismsAlzheimer DiseaseMental Health and PsychiatrymedicineAnimalsHumansPharmacologyAmyloid beta-PeptidesBiochemistry Genetics and Molecular Biology (all)lcsh:RBiology and Life SciencesProteinsComputational BiologyCell BiologyDUAL (cognitive architecture)medicine.diseaseDisease Models AnimalAgricultural and Biological Sciences (all)Specimen Preparation and TreatmentFeasibility StudiesDementialcsh:QClinical MedicineProtein MultimerizationPLoS ONE
researchProduct

Effect of radiofrequency and pelvic floor muscle training in the treatment of women with vaginal laxity: A study protocol

2021

Background Vaginal laxity is an underreported condition that negatively affects women’s sexual function and their relationships. Evidence-based studies are needed to better understand this complaint and to discuss its treatment options. Thus, we present a study protocol to compare the effect of radiofrequency and pelvic floor muscle training in the treatment of women with complaints of vaginal laxity. Methods/Design This is a prospective, parallel-group, two-arm, randomized clinical trial (Registry: RBR-2zdvfp–REBEC). Participants will be randomly assigned to one of the two groups of intervention (Radiofrequency or Pelvic Floor Muscle Training). The study will be performed in the Urogyneco…

Muscle PhysiologyMuscle FunctionsPhysiologyRadio WavesMaternal HealthAmbulatory Care Facilitieslaw.inventionUrogynecologyStudy ProtocolLabor and DeliveryRandomized controlled trialQuality of lifelawMedicine and Health SciencesOutpatient clinicRegistriesMultidisciplinaryQRObstetrics and Gynecologymedicine.anatomical_structureVaginaMedicineMuscle Contractionmedicine.medical_specialtyDrug Research and DevelopmentUrologyScienceSurgical and Invasive Medical ProceduresResearch and Analysis MethodsPelvic Floor MuscleIntervention (counseling)medicineClinical TrialsOutpatient ClinicsPharmacologyIncontinencebusiness.industryBiology and Life SciencesPelvic FloorRandomized Controlled TrialsHealth CareHealth Care FacilitiesPhysical therapyQuality of LifeBirthWomen's HealthSelf ReportClinical MedicineSexual functionbusinessPLoS ONE
researchProduct

Progressive active mobilization with dose control and training load in critically ill patients (PROMOB): Protocol for a randomized controlled trial

2020

The dose of progressive active mobilization is still uncertain. The purpose of this study is to identify if the addition of a protocol of progressive active mobilization with dose and training load control to usual care is effective in reducing the length of stay in intensive care unit (ICU) and the improvement of the functioning, incidence of ICU-acquired weakness (ICUAW), mechanical ventilation duration and mortality rate in patients hospitalized in ICU. It is Double-blind randomised clinical trial. The setting for this trial will be medical and surgical ICU of a university hospital. The study participants will be 118 patients aged> 18 years admitted to ICU for less than 72 hours. Partici…

Muscle PhysiologyMuscle FunctionsPhysiologymedicine.medical_treatmentHamstring MusclesKaplan-Meier EstimateQuadriceps Musclelaw.inventionMathematical and Statistical Techniques0302 clinical medicineClinical ProtocolsRandomized controlled triallawMedicine and Health SciencesPublic and Occupational Health030212 general & internal medicineYoung adultRandomized Controlled Trials as TopicMultidisciplinaryMortality rateStatisticsQRMetaanalysisIntensive care unitSports ScienceHospitalsIntensive Care UnitsStrength TrainingPhysical SciencesMedicinemedicine.symptomAdultWeaknessmedicine.medical_specialtyDrug Research and DevelopmentDeath RatesStrength trainingCritical IllnessScienceResearch and Analysis MethodsYoung Adult03 medical and health sciencesDouble-Blind MethodPopulation MetricsRegistered Report ProtocolmedicineHumansClinical TrialsMuscle StrengthSports and Exercise MedicineStatistical MethodsExercisePharmacologyMechanical ventilationPopulation Biologybusiness.industryBiology and Life Sciences030208 emergency & critical care medicinePhysical ActivityLength of StayRespiration ArtificialRandomized Controlled TrialsHealth CareClinical trialPhysical FitnessHealth Care FacilitiesPhysical therapyClinical MedicinebusinessMathematicsPLOS ONE
researchProduct

Usual Care and Informed Consent in Clinical Trials of Oxygen Management in Extremely Premature Infants

2016

Objective The adequacy of informed consent in the Surfactant, Positive Pressure, and Pulse Oximetry Randomized Trial (SUPPORT) has been questioned. SUPPORT investigators and publishing editors, heads of government study funding agencies, and many ethicists have argued that informed consent was adequate because the two oxygen saturation target ranges studied fell within a range commonly recommended in guidelines. We sought to determine whether each oxygen target as studied in SUPPORT and four similar randomized controlled trials (RCTs) was consistent with usual care. Design/Participants/Setting PubMed, EMBASE, Web of Science, and Scopus were searched for English articles back to 1990 providi…

PediatricsComparative Effectiveness ResearchAlternative medicinePsychological interventionlcsh:MedicineNeonatal Carelaw.inventionDatabase and Informatics Methods0302 clinical medicineRandomized controlled triallawInformed consentMedicine and Health Sciences030212 general & internal medicineOximetryDatabase Searchinglcsh:ScienceRandomized Controlled Trials as TopicMultidisciplinarymedicine.diagnostic_testHospitalsInformed Consent By MinorsChemistryIntensive Care UnitsResearch DesignInfant Extremely PrematurePhysical SciencesResearch ArticleChemical ElementsAdultmedicine.medical_specialtyDrug Research and DevelopmentClinical Research DesignDeath RatesComparative effectiveness researchResearch and Analysis Methods03 medical and health sciencesPopulation Metrics030225 pediatricsmedicineHumansClinical TrialsIntensive care medicineOxygen saturationDemographyPharmacologyPopulation Biologybusiness.industrylcsh:RInfant NewbornBiology and Life SciencesRandomized Controlled TrialsClinical trialOxygenHealth CarePulse oximetryHealth Care FacilitiesPeople and PlacesIntensive Care Neonatallcsh:QClinical MedicinebusinessPLoS ONE
researchProduct

Tannins from Hamamelis virginiana Bark Extract: Characterization and Improvement of the Antiviral Efficacy against Influenza A Virus and Human Papill…

2014

Antiviral activity has been demonstrated for different tannin-rich plant extracts. Since tannins of different classes and molecular weights are often found together in plant extracts and may differ in their antiviral activity, we have compared the effect against influenza A virus (IAV) of Hamamelis virginiana L. bark extract, fractions enriched in tannins of different molecular weights and individual tannins of defined structures, including pseudotannins. We demonstrate antiviral activity of the bark extract against different IAV strains, including the recently emerged H7N9, and show for the first time that a tannin-rich extract inhibits human papillomavirus (HPV) type 16 infection. As the …

PhytochemistryViral DiseasesPhytopharmacologylcsh:MedicineEpigallocatechin gallateMadin Darby Canine Kidney Cellschemistry.chemical_compoundMolecular Cell BiologyDrug DiscoveryTanninGallic acidlcsh:Sciencechemistry.chemical_classificationHuman papillomavirus 16MultidisciplinarybiologyChemistryInfectious DiseasesBiochemistryProanthocyanidinInfluenza A virusvisual_artPlant Barkvisual_art.visual_art_mediumMedicineBarkResearch Articlemedicine.drugDrugs and DevicesHuman Papillomavirus InfectionDrug Research and DevelopmentSexually Transmitted DiseasesHamamelisAntiviral AgentsDogsComplementary and Alternative MedicineInfluenza HumanTannic acidmedicineAnimalsHumansBiologyPlant Extractslcsh:RPapillomavirus InfectionsHamamelis virginianaInfluenzachemistrybiology.proteinlcsh:QTanninsNeuraminidasePLoS ONE
researchProduct

Pterostilbene-induced tumor cytotoxicity: a lysosomal membrane permeabilization-dependent mechanism.

2012

The phenolic phytoalexin resveratrol is well known for its health-promoting and anticancer properties. Its potential benefits are, however, limited due to its low bioavailability. Pterostilbene, a natural dimethoxylated analog of resveratrol, presents higher anticancer activity than resveratrol. The mechanisms by which this polyphenol acts against cancer cells are, however, unclear. Here, we show that pterostilbene effectively inhibits cancer cell growth and stimulates apoptosis and autophagosome accumulation in cancer cells of various origins. However, these mechanisms are not determinant in cell demise. Pterostilbene promotes cancer cell death via a mechanism involving lysosomal membrane …

PterostilbeneCancer Treatmentlcsh:MedicineApoptosisResveratrolBiochemistryLung and Intrathoracic Tumorschemistry.chemical_compoundMolecular cell biologyRNA interferenceNeoplasmsPhagosomesStilbenesDrug DiscoveryBreast TumorsBasic Cancer Researchlcsh:ScienceCytotoxicitySkin TumorsApoptotic Signaling CascadeCellular Stress ResponsesMultidisciplinaryMicroscopy ConfocalCell DeathMalignant MelanomaFlow CytometryCellular StructuresSignaling CascadesCell biologyEukaryotic CellsOncologyCaspasesMedicineCellular TypesCell DivisionResearch ArticleSignal TransductionProgrammed cell deathDrugs and DevicesDrug Research and DevelopmentMitosisAntineoplastic AgentsBiologyPermeabilityCell GrowthInhibitory Concentration 50NecrosisComplementary and Alternative MedicineCell Line TumorGastrointestinal TumorsAutophagyHumansHSP70 Heat-Shock ProteinsBiologyCell ProliferationDose-Response Relationship DrugL-Lactate DehydrogenaseCell growthlcsh:RAutophagyProteinsCancers and NeoplasmsRegulatory ProteinschemistrySubcellular OrganellesApoptosisResveratrolCancer celllcsh:QGene expressionLysosomesCytometryPloS one
researchProduct

eNOS Activation by HDL Is Impaired in Genetic CETP Deficiency.

2014

Mutations in the CETP gene resulting in defective CETP activity have been shown to cause remarkable elevations of plasma HDL-C levels, with the accumulation in plasma of large, buoyant HDL particles enriched in apolipoprotein E. Genetic CETP deficiency thus represents a unique tool to evaluate how structural alterations of HDL impact on HDL atheroprotective functions. Aim of the present study was to assess the ability of HDL obtained from CETP-deficient subjects to protect endothelial cells from the development of endothelial dysfunction. HDL isolated from one homozygous and seven heterozygous carriers of CETP null mutations were evaluated for their ability to down-regulate cytokine-induced…

Settore MED/09 - Medicina InternaCHOLESTEROL EFFLUXApolipoprotein BEpidemiologylcsh:MedicineANTIINFLAMMATORY PROPERTIESmedicine.disease_causeBiochemistryVascular Medicinechemistry.chemical_compoundHigh-density lipoproteinEnosMedicine and Health SciencesEndothelial dysfunctionlcsh:ScienceMutationMultidisciplinarybiologyHomozygoteCETP; eNOS; HDL;NeurochemistryLipidsGenetic EpidemiologyeNOSlipids (amino acids peptides and proteins)AnatomyNeurochemicalsLipoproteins HDLResearch Articlemedicine.medical_specialtyDrug Research and DevelopmentHDLNitric Oxide Synthase Type IIILipoproteinsENDOTHELIAL FUNCTIONINHIBITIONCardiologyDown-RegulationVascular Cell Adhesion Molecule-1Nitric OxideCELL-ADHESION MOLECULE-1Lipid Metabolism Inborn ErrorsESTER TRANSFER PROTEINInternal medicineCETPCholesterylester transfer proteinHuman Umbilical Vein Endothelial CellsmedicineHumansNITRIC-OXIDE SYNTHASEInflammationClinical GeneticsPharmacologyCholesterollcsh:RTorcetrapibEndothelial CellsBiology and Life SciencesProteinsnutritional and metabolic diseasesLipid MetabolismAtherosclerosismedicine.diseasebiology.organism_classificationCholesterol Ester Transfer Proteinscarbohydrates (lipids)MetabolismEndocrinologychemistryOther Clinical MedicineMutationImmunologyCardiovascular Anatomybiology.proteinlcsh:QTORCETRAPIBClinical MedicineHIGH-DENSITY-LIPOPROTEINSCAVENGER RECEPTOR BI
researchProduct

Ovine Carotid Artery-Derived Cells as an Optimized Supportive Cell Layer in 2-D Capillary Network Assays

2014

PLoS one 9(3), e91664 (2014). doi:10.1371/journal.pone.0091664

Vascular Endothelial Growth Factor APathologyCellBecaplerminlcsh:MedicineCardiovascularUmbilical veinUmbilical CordDrug DiscoveryMolecular Cell BiologyBiological Systems EngineeringMyocyteCardiovascular Imaginglcsh:ScienceMultidisciplinaryProto-Oncogene Proteins c-sisAnimal ModelsFlow CytometryEndothelial stem cellBevacizumabmedicine.anatomical_structureCarotid ArteriesMonoclonalMedicineImmunohistochemical AnalysisResearch ArticleBiotechnologymedicine.medical_specialtyCell typeDrugs and DevicesDrug Research and DevelopmentMyocytes Smooth MuscleImmunologyBiomedical EngineeringBioengineeringBiologyAntibodies Monoclonal HumanizedCell LineModel OrganismsVascular Biologymedicine.arterymedicineAnimalsHumansBiologySheeplcsh:REndothelial CellsFeeder CellsUmbilical arteryMolecular biologyVascular Endothelial Growth Factor Receptor-2Coculture TechniquesCapillariesCell cultureImmunologic Techniqueslcsh:QCytometry
researchProduct

Characteristics of clinical trials in rare vs. common diseases: A register-based Latvian study.

2017

Background Conducting clinical studies in small populations may be very challenging; therefore quality of clinical evidence may differ between rare and non-rare disease therapies. Objective This register-based study aims to evaluate the characteristics of clinical trials in rare diseases conducted in Latvia and compare them with clinical trials in more common conditions. Methods The EU Clinical Trials Register (clinicaltrialsregister.eu) was used to identify interventional clinical trials related to rare diseases (n = 51) and to compose a control group of clinical trials in non-rare diseases (n = 102) for further comparison of the trial characteristics. Results We found no significant diffe…

lcsh:MedicineDiseaseGeographical locationslaw.invention0302 clinical medicineRandomized controlled triallawOutcome Assessment Health CareClinical endpointMedicine and Health SciencesRegistrieslcsh:ScienceClinical Trials as TopicMultidisciplinaryDrug MarketingPhase III clinical investigationSurvival RateEuropeOncology030220 oncology & carcinogenesisMeta-analysisComparatorsEngineering and TechnologyPhase II clinical investigationResearch Articlemedicine.medical_specialtyRandomizationDrug Research and DevelopmentResearch and Analysis Methods03 medical and health sciencesRare DiseasesInternal medicinemedicineHumansClinical TrialsEuropean UnionSurvival ratePharmacologybusiness.industrylcsh:RLatviaRandomized Controlled TrialsClinical triallcsh:QClinical MedicinePeople and placesElectronicsbusiness030217 neurology & neurosurgeryRare diseasePloS one
researchProduct

Mid- to Long-Term Outcomes of Cervical Disc Arthroplasty versus Anterior Cervical Discectomy and Fusion for Treatment of Symptomatic Cervical Disc Di…

2015

Purpose This study aimed to investigate the mid- to long-term outcomes of cervical disc arthroplasty (CDA) versus anterior cervical discectomy and fusion (ACDF) for the treatment of 1-level or 2-level symptomatic cervical disc disease. Methods Medline, Embase, and the Cochrane Central Register of Controlled Trials databases were searched to identify relevant randomized controlled trials that reported mid- to long-term outcomes (at least 48 months) of CDA versus ACDF. All data were analyzed by Review Manager 5.3 software. The relative risk (RR) and 95% confidence intervals (CIs) were calculated for dichotomous variables. The weighted mean difference (WMD) and 95%CIs were calculated for conti…

medicine.medical_treatmentlcsh:MedicineAnterior cervical discectomy and fusionIntervertebral Disc Degenerationlaw.inventionDatabase and Informatics MethodsMathematical and Statistical Techniques0302 clinical medicineRandomized controlled triallawMedicine and Health SciencesDatabase Searchinglcsh:ScienceRandomized Controlled Trials as Topic030222 orthopedicsMultidisciplinaryResearch AssessmentTreatment Outcomemedicine.anatomical_structureResearch DesignMeta-analysisPhysical SciencesCervical VertebraeIntervertebral Disc DisplacementStatistics (Mathematics)DiskectomyResearch ArticleCervical vertebraemedicine.medical_specialtyDrug Research and DevelopmentSystematic ReviewsClinical Research DesignVisual analogue scaleSurgical and Invasive Medical ProceduresResearch and Analysis MethodsArthroplasty03 medical and health sciencesMusculoskeletal System ProceduresDiscectomyConfidence IntervalsmedicineHumansClinical TrialsStatistical MethodsPharmacologybusiness.industrylcsh:RArthroplastyRandomized Controlled TrialsSurgeryRelative risklcsh:QAdverse EventsClinical MedicinebusinessMathematics030217 neurology & neurosurgeryMeta-AnalysisPLoS ONE
researchProduct